Sotio Biotech (private company)
See something wrong or missing? Let us know
Offices:Prague
Industry:BiotechHealth servicesManufacturing
Business model:B2B
Sotio is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 316.35M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Sotio Biotech
Name | Criteria | |
---|---|---|
![]() |
CatalYm
60%
|
|
![]() |
InnovaFeed SAS
60%
|
|
![]() |
Memo Therapeutics
60%
|
|
![]() |
Peptomyc
60%
|
|
![]() |
Salvia BioElectronics
60%
|
|
![]() |
Synendos Therapeutics
60%
|
|
![]() |
Cytoki Pharma
60%
|
|
![]() |
Oxford Nanopore Technologies
60%
|
|
![]() |
AMSilk
60%
|
|
![]() |
Xenothera
60%
|
|